Endovascular and Percutaneous Treatment of Pediatric Portosystemic Varices: a Case Review

Total Page:16

File Type:pdf, Size:1020Kb

Endovascular and Percutaneous Treatment of Pediatric Portosystemic Varices: a Case Review Published online: 2019-08-27 214 Endovascular and Percutaneous Treatment of Pediatric Portosystemic Varices: A Case Review Alexander Dabrowiecki, MD1 Eric J. Monroe, MD2 Rene Romero, MD3 Anne E. Gill, MD1,4 C. Matthew Hawkins, MD1,4 1 Department of Radiology and Imaging Sciences, Emory University Address for correspondence Alexander Dabrowiecki, MD, 1364 School of Medicine, Atlanta, Georgia Clifton Rd. NE, Suite #D112, Atlanta, GA 30322 2 Department of Interventional Radiology, Seattle Children’s Hospital, (e-mail: [email protected]). Seattle, Washington 3 Department of Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, Children’s Pediatric Institute, Children’s Healthcare of Atlanta and Emory University, Atlanta, Georgia 4 Division of Interventional Radiology and Image Guided Medicine, Children’s Pediatric Institute, Children’s Healthcare of Atlanta and Emory University, Atlanta, Georgia Dig Dis Interv 2019;3:214–226. Abstract Portal hypertension is a significant cause of morbidity and mortality in pediatric patients. Complications of portal hypertension include development of portosystemic varices. The most common type of portosystemic varices are gastroesophageal varices; however, other ectopic varices can also be a cause of recurrent, life-threatening gastrointestinal bleeding. Problematic ectopic varices include isolated gastric, ano- rectal, small bowel, roux-limb, and stomal varices. There are no standardized treatment Keywords guidelines on how to manage ectopic varices in children; however, new innovations in ► portosystemic varices endovascular treatment options provide potential therapeutic alternatives when ► ectopic varices varices are refractory to conventional therapy. This review provides a case-based ► venous intervention literature review for endovascular treatment of isolated gastric, anorectal, small bowel, ► pediatric roux-limb, and stomal ectopic varices in children (age 0-9 years) and adolescents (age interventions 10-19 years). Portal hypertension in children is a significant cause of feared complication of all types of EcV. Traditionally, in morbidity and mortality. One common complication associ- children, most EcV have been treated both endoscopically ated with portal hypertension is the development of porto- and surgically. However, minimally invasive percutaneous systemic varices, such as gastroesophageal and other ectopic and endovascular therapies have evolved as potential thera- varices (EcV). Portal hypertension in adults is defined as a peutic options to treat EcV not amenable to endoscopic or hepatic venous pressure gradient greater than 5 mm Hg, and surgical treatment in children. Transjugular intrahepatic variceal formation occurs from a hepatic venous pressure portosystemic shunt (TIPS) creation has been extensively This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. gradient 10 mm Hg leading to venous collateralization, described in the peer-review literature to treat pediatric – classically in predictable locations.1 The most common type esophageal and gastroesophageal varices,2 5 and will, thus, of varices are esophageal and gastroesophageal varices. not be extensively reviewed herein. This review, rather, However, less-common, yet equally as problematic, EcV focuses on the literature to date in a case-based and loca- include isolated gastric, anorectal, small bowel (most com- tion-based approach to percutaneous and/or endovascular monly duodenal), roux-limb, and stomal varices (►Figs. 1 treatment of pediatric isolated gastric, anorectal, small bow- and 2). Acute life-threatening variceal bleeding is the most el, roux-limb, and stomal EcV. received Issue Theme Pediatric Gastrointestinal Copyright © 2019 by Thieme Medical DOI https://doi.org/ April 10, 2019 Interventions; Eric J. Monroe, MD Publishers, Inc., 333 Seventh Avenue, 10.1055/s-0039-1694978. accepted after revision New York, NY 10001, USA. ISSN 2472-8721. June 6, 2019 Tel: +1(212) 584-4662. published online August 27, 2019 Treatment of Pediatric Portosystemic Varices Dabrowiecki et al. 215 Fig. 1 Drawing illustrates the common portosystemic venous collateral Fig. 2 Drawing illustrates the various routes that can be used to pathways: the left gastric (coronary) and azygos veins at the lower access the portal venous system in complicated portal hypertension, a b esophagus ( ); the splenic and left renal-adrenal veins at the spleen ( ); the including transjugular (a), transhepatic (b), trans-splenic (c), tran- c superior rectal and middle-inferior rectal veins at the anal canal ( ); the veins sumbilical (d), transvariceal (stomal) (e), and transfemoral (systemic- of the ligamentum teres and the superior-inferior epigastric veins at the portal) (f) routes. (Referenced from Glen Oomen, MSc, McMaster d umbilicus ( ); and the colonic-mesenteric veins, body wall veins, and IVC in University, Dundas, Ontario, Canada.94) the retroperitoneum (e). (Referenced from Glen Oomen, MSc, McMaster University, Dundas, Ontario, Canada.) The pediatric literature is limited in its description of the However, more recent literature demonstrates pediatric risk factors for developing EcV, as invasive hemodynamic mortality from variceal bleeding is uncommon,10 although measures are rarely performed and thus inferences are made long-term morbidity in these patients is not well described.6 from the adult literature including using similar hepatic vein Often times, gastrointestinal bleeding from a ruptured varix pressure gradient thresholds as adults.6 In adults, there is a is the most common presenting symptom of portal hyper- This document was downloaded for personal use only. Unauthorized distribution is strictly prohibited. direct correlation between the degree of hepatic cirrhosis tension. Life-threatening bleeding and complications occur measured by Child Pugh or Model for End-Stage Liver Disease mainly in patients with portal hypertension secondary to (MELD) scores and degree of hyperdynamic circulation and hepatic cirrhosis due to the downstream complications of portal pressure gradient.7 Up to 60% of patients with decom- hepatic decompensation. pensated cirrhosis (as evidenced by coagulopathy, ascites, and hepatic encephalopathy) and up to 30% of patients with Pediatric Etiologies compensated cirrhosis have varices. Approximately 10% to 20% of these patients’ varices increase in size within 1 to 2 There are fundamental differences in the pathophysiology years. Importantly, size of esophageal varices is directly resulting in portal hypertension and subsequent EcV in correlated with risk of variceal bleeding8 and variceal size pediatric patients when compared to adults. There are is directly related to the degree of hepatic vein wedge many different causes of pediatric portal hypertension, pressure gradient elevation. Significant acute variceal bleed- which can further be subdivided into extrahepatic (prehe- ing is associated with up to 50% mortality9 in adults, and, patic and infrahepatic), intrahepatic, and post hepatic therefore, close attention to patients with EcV is necessary. (►Table 1). Digestive Disease Interventions Vol. 3 No. 3/2019 216 Treatment of Pediatric Portosystemic Varices Dabrowiecki et al. – Table 1 Causes of pediatric portal hypertension91 93 clinical prediction rules have been created based on spleen size, hypoalbuminemia, and platelet count to predict risk of Intrahepatic Biliary Biliary atresia forming esophageal varices.11,18 However, no such prediction disease Progressive familial intrahepatic rules have been delineated for the less common types of EcV cholestasis Primary sclerosing cholangitis discussed in this review likely due to the lack of published Cystic fibrosis treatment and outcomes data . Intestinal failure-associated liver disease Hepatic Autoimmune hepatitis Baveno Consensus Recommendations: disease Chronic viral hepatitis B/C Prophylaxis versus Acute Variceal Bleeding Alpha1-Antitrypsin deficiency Nonalcoholic fatty liver disease Beginning in 1990, in response to the scarce literature on Wilson’sdisease approaches to management of pediatric variceal bleeding, an Glycogen storage disease expert panel has convened every 5 years in Baveno, Italy, to Fibrotic Congenital hepatic fibrosis explore the data in pediatric variceal bleeding. The most disease Caroli disease recent consortium of the “Controversies in the Management Prehepatic Portal vein Portal vein thrombosis of Varices in Children—An International Forum” met in 2015, fi occlusion Tumor in ltration or and from this meeting, experts recommend no specific compression Congenital atresia/agenesis primary prophylaxis with either medication (nonselective beta-blockers), endoscopic variceal ligation, or sclerotherapy Splenic vein thrombosis based on the lack of evidence. Meso-Rex Bypass (a vascular graft between the superior mesenteric vein and left portal Increased Arteriovenous fistula fi portal flow vein) may be bene cial for primary and secondary prophy- laxis in certain cases of extrahepatic portal vein occlusion.19 Nodular Drug therapy regenerative (6-thioguanine and Endoscopic ligation and sclerotherapy can be performed to azathioprine) achieve hemostasis in gastroesophageal varices. In addition, Turner syndrome for acute variceal bleeding, octreotide has been shown to be Portal Schistosomiasis safe and effective in the majority of cases.20 stenosis Idiopathic cause Within the newest 2015 Baveno recommendations, endo- HIV infection vascular therapy, specifically TIPS, was not directly addressed.
Recommended publications
  • Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia As a Stand-Alone Procedure Or As a Bridge Toward Liver Transplantation
    medicina Article Biological and Histological Assessment of the Hepatoportoenterostomy Role in Biliary Atresia as a Stand-Alone Procedure or as a Bridge toward Liver Transplantation Raluca-Cristina Apostu 1, Vlad Fagarasan 1 , Catalin C. Ciuce 1, Radu Drasovean 1 , Dan Gheban 2, Radu Razvan Scurtu 1,*, Alina Grama 3, Ana Cristina Stefanescu 3, Constantin Ciuce 1 and Tudor Lucian Pop 3 1 Department of Surgery, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400000 Cluj-Napoca; First Surgical Clinic, Emergency County Hospital, 3-5 Clinicilor Street, 400006 Cluj-Napoca, Romania; [email protected] or [email protected] (R.-C.A.); [email protected] (V.F.); [email protected] (C.C.C.); [email protected] (R.D.); [email protected] (C.C.) 2 Department of Pathology, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400000 Cluj-Napoca; 4 th Pediatric Clinic, Emergency Clinical Hospital for Children, 68 Motilor Street, 400000 Cluj-Napoca, Romania; [email protected] 3 Department of Pediatrics, “Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, 8 Victor Babes Street, 400000 Cluj-Napoca; 2nd Pediatric Clinic, Emergency Clinical Hospital for Children, 400177 Cluj-Napoca, Romania; [email protected] (A.G.); [email protected] (A.C.S.); [email protected] (T.L.P.) * Correspondence: [email protected]; Tel.: +40-744-704-012 Abstract: Background and objectives: In patients with biliary atresia (BA), hepatoportoenterostomy (HPE) is still a valuable therapeutic tool for prolonged survival or a safer transition to liver transplantation. Citation: Apostu, R.-C.; Fagarasan, V.; The main focus today is towards efficient screening programs, a faster diagnostic, and prompt treatment.
    [Show full text]
  • General Signs and Symptoms of Abdominal Diseases
    General signs and symptoms of abdominal diseases Dr. Förhécz Zsolt Semmelweis University 3rd Department of Internal Medicine Faculty of Medicine, 3rd Year 2018/2019 1st Semester • For descriptive purposes, the abdomen is divided by imaginary lines crossing at the umbilicus, forming the right upper, right lower, left upper, and left lower quadrants. • Another system divides the abdomen into nine sections. Terms for three of them are commonly used: epigastric, umbilical, and hypogastric, or suprapubic Common or Concerning Symptoms • Indigestion or anorexia • Nausea, vomiting, or hematemesis • Abdominal pain • Dysphagia and/or odynophagia • Change in bowel function • Constipation or diarrhea • Jaundice “How is your appetite?” • Anorexia, nausea, vomiting in many gastrointestinal disorders; and – also in pregnancy, – diabetic ketoacidosis, – adrenal insufficiency, – hypercalcemia, – uremia, – liver disease, – emotional states, – adverse drug reactions – Induced but without nausea in anorexia/ bulimia. • Anorexia is a loss or lack of appetite. • Some patients may not actually vomit but raise esophageal or gastric contents in the absence of nausea or retching, called regurgitation. – in esophageal narrowing from stricture or cancer; also with incompetent gastroesophageal sphincter • Ask about any vomitus or regurgitated material and inspect it yourself if possible!!!! – What color is it? – What does the vomitus smell like? – How much has there been? – Ask specifically if it contains any blood and try to determine how much? • Fecal odor – in small bowel obstruction – or gastrocolic fistula • Gastric juice is clear or mucoid. Small amounts of yellowish or greenish bile are common and have no special significance. • Brownish or blackish vomitus with a “coffee- grounds” appearance suggests blood altered by gastric acid.
    [Show full text]
  • Editorial Has the Time Come for Cyanoacrylate Injection to Become the Standard-Of-Care for Gastric Varices?
    Tropical Gastroenterology 2010;31(3):141–144 Editorial Has the time come for cyanoacrylate injection to become the standard-of-care for gastric varices? Radha K. Dhiman, Narendra Chowdhry, Yogesh K Chawla The prevalence of gastric varices varies between 5% and 33% among patients with portal Department of Hepatology, hypertension with a reported incidence of bleeding of about 25% in 2 years and with a higher Postgraduate Institute of Medical bleeding incidence for fundal varices.1 Risk factors for gastric variceal hemorrhage include the education Research (PGIMER), size of fundal varices [more with large varices (as >10 mm)], Child class (C>B>A), and endoscopic Chandigarh, India presence of variceal red spots (defined as localized reddish mucosal area or spots on the mucosal surface of a varix).2 Gastric varices bleed less commonly as compared to esophageal Correspondence: Dr. Radha K. Dhiman, varices (25% versus 64%, respectively) but they bleed more severely, require more blood E-mail: [email protected] transfusions and are associated with increased mortality.3,4 The approach to optimal treatment for gastric varices remains controversial due to a lack of large, randomized, controlled trials and no clear clinical consensus. The endoscopic treatment modalities depend to a large extent on an accurate categorization of gastric varices. This classification categorizes gastric varices on the basis of their location in the stomach and their relationship with esophageal varices.1,5 Gastroesophageal varices are associated with varices along
    [Show full text]
  • Chapter 156: Upper Gastrointestinal Bleeding
    8/23/2018 Principles and Practice of Hospital Medicine, 2e > Chapter 156: Upper Gastrointestinal Bleeding Stephen R. Rotman; John R. Saltzman INTRODUCTION Key Clinical Questions What is the timing and treatment of peptic ulcer disease? What are the factors in diagnosis and treatment of aortoenteric fistula? What treatments are available for each etiology of upper GI bleeding? What is the appropriate management and follow-up of variceal bleeding? How do you estimate the severity of bleeding so that you can triage appropriate patients to the ICU, medical floor, or observation unit? Which patients are more likely to rebleed and hence require continued observation in the hospital aer their bleeding has apparently stopped, and for how long? Upper gastrointestinal (GI) bleeding is responsible for over 300,000 hospitalizations per year in the United States. An additional 100,000 to 150,000 patients develop upper GI bleeding during hospitalizations. The annual cost of treating nonvariceal acute upper GI bleeding in the United States exceeds $7 billion. Upper GI bleeding is defined as a bleeding source in the GI tract proximal to the ligament of Treitz. The presentation varies depending on the nature and severity of bleeding and includes hematemesis, melena, hematochezia (in rapid upper GI bleeding), and anemia with heme-positive stools. Bleeding can be associated with changes in vital signs, including tachycardia and hypotension including orthostatic hypotension. Given the range of presentations, pinpointing the nature and severity of GI bleeding may be a challenging task. The natural history of nonvariceal upper GI bleeding is that 80% of patients will stop bleeding spontaneously and no further urgent intervention will be needed.
    [Show full text]
  • Overview of Esophageal and Gastric Varices
    pISSN 2287-2728 eISSN 2287-285X https://doi.org/10.3350/cmh.2020.0022 Review Clinical and Molecular Hepatology 2020;26:444-460 Managing liver cirrhotic complications: Overview of esophageal and gastric varices Cosmas Rinaldi Adithya Lesmana1,2, Monica Raharjo1, and Rino A. Gani1 1Division of Hepatobiliary, Department of Internal Medicine, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta; 2Digestive Disease & GI Oncology Centre, Medistra Hospital, Jakarta, Indonesia Managing liver cirrhosis in clinical practice is still a challenging problem as its progression is associated with serious complications, such as variceal bleeding that may increase mortality. Portal hypertension (PH) is the main key for the development of liver cirrhosis complications. Portal pressure above 10 mmHg, termed as clinically significant portal hypertension, is associated with formation of varices; meanwhile, portal pressure above 12 mmHg is associated with variceal bleeding. Hepatic vein pressure gradient measurement and esophagogastroduodenoscopy remain the gold standard for assessing portal pressure and detecting varices. Recently, non-invasive methods have been studied for evaluation of portal pressure and varices detection in liver cirrhotic patients. Various guidelines have been published for clinicians’ guidance in the management of esophagogastric varices which aims to prevent development of varices, acute variceal bleeding, and variceal rebleeding. This writing provides a comprehensive review on development of PH and varices in liver cirrhosis patients and its management based on current international guidelines and real experience in Indonesia. (Clin Mol Hepatol 2020;26:444-460) Keywords: Liver cirrhosis; Hypertension, Portal; Esophageal and gastric varices INTRODUCTION tes, hepatic encephalopathy, coagulation dysfunction, hepatorenal syndrome, and even cardiac and pulmonary complications.
    [Show full text]
  • Intrahepatic Cysts in Biliary Atresia Aftersuccessful
    Arch Dis Child: first published as 10.1136/adc.59.3.274 on 1 March 1984. Downloaded from 274 Sinaasappel, den Ouden, Luyendijk, and Degenhart The reason for the patient's persistent vomiting in 3 Menke JA, Stallworth RE, Bindstadt DH, Strano AJ, the first five months of life may well have been Wallace SE. Medication bezoar in a neonate. Am J Dis Child 1982;136:72-3. a slower development of his antireflux mechanism, 4 Metlay LA, Klionsky BC. An unusual gastric bezoar in a but we have not been able to confirm this newborn: polystyrene resin and candida albicans. J Pediatr hypothesis. 1983;102:121-3. 5 Portuguez-Malavasi A, Aranda JV. Antacid bezoar in a newborn. Pediatrics 1979;63:679- 80. References 6 Hewitt GJ, Benham ES. A complication of gaviscon in' a neonate-'the gavisconoma'. Aust Paediatr J 1976;12:47-8. O'Brien D, Rodgerson DO, Ibbott FA. Laboratory manual of pediatric micro- and ultramicro biochemical techniques. 4th ed. Correspondence to Dr M Sinaasappel, Department of Paediatrics, New York: Harper & Row, 1968:231. Gastro-enterological Division, Erasmus University and University 2 Schreiner RL, Lemons JA, Gresham EL. A new complication Hospital, Rotterdam, The Netherlands. of nutritial management of the low-birth-weight infant. Pediat- rics 1979;63:683-4. Received 7 November 1983 Intrahepatic cysts in biliary atresia after successful hepatoportoenterostomy S SAITO, T NISHINA, AND Y TSUCHIDA Department ofPaediatric Surgery, University of Tokyo, Japan SUMMARY A patient with an unusual association of dilated and cord like portions of the extrahepatic biliary atresia and two intrahepatic cysts is reported.
    [Show full text]
  • Diagnosis and Management of Ectopic Varices
    Gastrointest Interv 2012; 1:3–10 Contents lists available at SciVerse ScienceDirect Gastrointestinal Intervention journal homepage: www.gi-intervention.org Review Article Diagnosis and management of ectopic varices Nabeel M. Akhter, Ziv J. Haskal* abstract Ectopic varices are large portosystemic collaterals in locations other than the gastroesophageal region. They account for up to 5% of all variceal bleeding; however, hemorrhage can be massive with mortality reaching up to 40%. Given their sporadic nature, literature is limited to case reports, small case series and reviews, without guidelines on management. As the source of bleeding can be obscure, the physician managing such a patient needs to establish diagnosis early. Multislice computed tomography with contrast and reformatted images is a rapid and validated modality in establishing diagnosis. Further management is dictated by location, underlying cause of ectopic varices and available expertise. Therapeutic options may include double balloon enteroscopy, transcatheter embolization or sclerotherapy, with or without portosystemic decompression, i.e., transjugular intrahepatic portosystemic shunts. In this article we review the prevalence, etiopathogenesis, anatomy, presentation, and diagnosis of ectopic varices with emphasis on recent advances in management. Copyright Ó 2012, Society of Gastrointestinal Intervention. Published by Elsevier. All rights reserved. Keywords: Balloon-occluded retrograde transvenous obliteration, Ectopic varices, Portal hypertension, Percutaneous embolization,
    [Show full text]
  • Palliative Care in Advanced Liver Disease (Marsano 2018)
    Palliative Care in Advanced Liver Disease Luis Marsano, MD 2018 Mortality in Cirrhosis • Stable Cirrhosis: – Prognosis determined by MELD-Na score – Provides 90 day mortality. – http://www.mdcalc.com/meldna-meld-na-score-for-liver-cirrhosis/ • Acute on Chronic Liver Failure (ACLF) – Mortality Provided by CLIF-C ACLF Calculator – Provides mortality at 1, 3, 6 and 12 months. – http://www.clifresearch.com/ToolsCalculators.aspx • Acute Decompensation (without ACLF): – Mortality Provided by CLIF-C Acute decompensation Calculator – Provides mortality at 1, 3, 6 and 12 months. – http://www.clifresearch.com/ToolsCalculators.aspx • Survival of Ambulatory Patients with HCC (MESIAH) – Provides survival at 1, 3, 6, 12, 24 and 36 months. – https://www.mayoclinic.org/medical-professionals/model-end-stage-liver- disease/model-estimate-survival-ambulatory-hepatocellular-carcinoma-patients- mesiah Acute Decompensation Type and Mortality Organ Failure in Acute-on-Chronic Liver Failure Organ Failure Mortality Impact Frequency of Organ Failure 48% have >/= 2 Organ Failures The MESIAH Score Model of Estimated Survival In Ambulatory patients with HCC Complications of Cirrhosis Affecting Palliative Care • Ascites and Hepatic Hydrothorax. • Hyponatremia. • Hepatorenal syndrome. • Hepatic Encephalopathy. • Malnutrition/ Anorexia. • GI bleeding: Varices, Portal gastropathy & Gastric Antral Vascular Ectasia • Pruritus • Hepatopulmonary Syndrome. Difficult Decisions with Shifting Balance • Is patient a liver transplant candidate? • Effect of illness in: – patient’s survival – patient’s Quality of Life • patient’s relation to family • family’s Quality of Life • Effect of therapy in: – patient’s survival – patient’s Quality of Life • patient’s relation to family • family’s Quality of life Ascites and Palliation • PATHOGENESIS • CONSEQUENCES • Hepatic sinusoidal HTN • Abdominal distention with early stimulates hepatic satiety.
    [Show full text]
  • American Surgical Association
    AMERICAN SURGICAL ASSOCIATION Program of the 131st Annual Meeting Boca Raton Resort & Club Boca Raton, Florida Thursday, April 14th Friday, April 15th Saturday, April 16th 2011 Table of Contents Officers and Council ....................................................................2 Committees ..................................................................................3 Foundation Trustees.....................................................................5 Representatives ............................................................................6 Future Meetings ...........................................................................7 General Information.....................................................................8 Continuing Medical Education Accreditation Information........10 AMERICAN Program Committee Disclosure List..........................................13* SURGICAL Faculty Disclosure List...............................................................13* Author Disclosure List...............................................................14* ASSOCIATION Discussant Disclosure List.........................................................22* Schedule-at-a-Glance.................................................................24 Program Outline.........................................................................26 Program Program Detail and Abstracts.....................................................41 of the Alphabetical Directory of Fellows.............................................94* 131st Annual
    [Show full text]
  • Insights Into the Management of Anorectal Disease in the Coronavirus 2019 Disease Era
    University of Massachusetts Medical School eScholarship@UMMS COVID-19 Publications by UMMS Authors 2021-07-09 Insights into the management of anorectal disease in the coronavirus 2019 disease era Waseem Amjad Albany Medical Center Et al. Let us know how access to this document benefits ou.y Follow this and additional works at: https://escholarship.umassmed.edu/covid19 Part of the Digestive System Diseases Commons, Gastroenterology Commons, Infectious Disease Commons, Telemedicine Commons, and the Virus Diseases Commons Repository Citation Amjad W, Haider R, Malik A, Qureshi W. (2021). Insights into the management of anorectal disease in the coronavirus 2019 disease era. COVID-19 Publications by UMMS Authors. https://doi.org/10.1177/ 17562848211028117. Retrieved from https://escholarship.umassmed.edu/covid19/285 Creative Commons License This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License This material is brought to you by eScholarship@UMMS. It has been accepted for inclusion in COVID-19 Publications by UMMS Authors by an authorized administrator of eScholarship@UMMS. For more information, please contact [email protected]. TAG0010.1177/17562848211028117Therapeutic Advances in GastroenterologyW Amjad, R Haider 1028117research-article20212021 Advances and Future Perspectives in Colorectal Cancer Special Collection Therapeutic Advances in Gastroenterology Review Ther Adv Gastroenterol Insights into the management of anorectal 2021, Vol. 14: 1–13 https://doi.org/10.1177/17562848211028117DOI: 10.1177/ disease in the coronavirus 2019 disease era https://doi.org/10.1177/1756284821102811717562848211028117 © The Author(s), 2021. Article reuse guidelines: Waseem Amjad, Rabbia Haider, Adnan Malik and Waqas T. Qureshi sagepub.com/journals- permissions Abstract: Coronavirus 2019 disease (COVID-19) has created major impacts on public health.
    [Show full text]
  • Massive Gastric Variceal Hemorrhage Due to Splenic Vein Thrombosis
    Journal of Liver Research, Disorders & Therapy Case Report Open Access Massive gastric variceal hemorrhage due to splenic vein thrombosis; a rare initial presentation of asymptomatic metastatic pancreatic adenocarcinoma Introduction Volume 4 Issue 3 - 2018 Isolated sinistral portal hypertension (SPH) is extremely rare, 1,2 representing less than 5% of all portal hypertension cases. Splenic Kelley Nguyen,1 Daniel S Zhang,2 Mark A vein thrombosis is typically discovered incidentally on imaging and Sultenfuss,3 David W Victor III2 is often asymptomatic. Variceal bleeding can ensue in SPH, which 1Texas A&M University College of Medicine, USA develops due to increased pressure on the left side of the portal system.3 2Department of Medicine, Section of Gastroenterology and While most gastric varices are caused by cirrhotic portal hypertension, Hepatology, Methodist Hospital, USA rare cases occur due to non-cirrhotic splenic venous thrombosis. Here, 3Department of Radiology, Methodist Hospital, USA we present massive gastric variceal bleeding splenic vein thrombosis as the initial presentation of pancreatic adenocarcinoma. Correspondence: David Victor III, Associate Professor of Clinical Medicine, Weill-Cornell Medical College, Section of Case report Hepatology & Transplant Medicine, Sherrie and Alan Conover Center for Liver Disease and Transplantation, Houston A 71-year old man presented to the emergency department with Methodist J.C. Walter , Transplant Center, Houston Methodist acute onset massive hematemesis and epigastric pain. He denied Hospital, 6550, annin St., Ste 1201 Houston, TX 77030, USA, Tel jaundice, NSAID use or prior hematemesis. Relevant medical 7134-4133-72, Email [email protected] history included heavy tobacco use in the past but denied alcohol Received: June 18, 2018 | Published: June 25, 2018 use.
    [Show full text]
  • Copyright © ESPGHAN and NASPGHAN. All Rights Reserved
    Journal of Pediatric Gastroenterology and Nutrition, Publish Ahead of Print DOI : 10.1097/MPG.0000000000002836 Cholangitis in Patients with Biliary Atresia Receiving Hepatoportoenterostomy: A National Database Study Katherine Cheng, M.D.1 Jean P. Molleston, M.D.2 William E. Bennett, Jr., M.D., M.S.2,3 1. Department of Pediatrics, 2. Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN 3. Section of Pediatric and Adolescent Comparative Effectiveness Research, Indiana University School of Medicine, Indianapolis, IN, USA Abstract: Introduction: Biliary atresia (BA) is a progressive form of liver disease in the neonatal period usually requiring hepatoportoenterostomy (HPE). Cholangitis is a common sequelae of HPE, but data about which patients are at risk for this complication are limited. Objective: To determine risk factors associated with cholangitis in a large retrospective cohort after HPE. Methods: The Pediatric Health Information System (PHIS) was queried for BA (ICD-9 975.61) and HPE (ICD-9-CM 51.37) admissions from 2004-2013. We performed univariate Copyright © ESPGHAN and NASPGHAN. All rights reserved. analysis and linear regression with dependent variables of ≥ 2 or ≥ 5 episodes of cholangitis, and independent variables of age at time of HPE, race, ethnicity, gender, insurance, ursodeoxycholic acid (UDCA) use, steroid use, presence of esophageal varices (EV), and portal hypertension (PH). Results: We identified 1,112 subjects with a median age at HPE of 63 days and median number of cholangitis episodes of 2 within 2 years. On multiple regression analysis, black race (OR 1.51, p = 0.044) and presence of PH (OR 2.24, p < 0.001) were associated with increased risk of ≥ 2 episodes of cholangitis, while HPE at > 90 days was associated with less risk (OR 0.46, p = 0.001).
    [Show full text]